Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:30:04 EST Sat 07 Feb 2026
Enter Symbol
or Name
USA
CA



Q:LNTH - LANTHEUS HOLDINGS INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
LNTH - Q9.964.54·66.373.764.89+0.030.0846.654,00811,58165.51  66.05  63.84111.29  47.2717:23:27Jan 0215 min RT 2¢

Recent Trades - Last 10 of 11581
Time ETExPriceChangeVolume
17:23:27Q65.000.141
16:10:04Q64.890.031
16:10:04Q64.890.031
16:04:38Q64.890.031
16:04:35Q64.890.031
16:04:12Q64.890.031
16:04:12Q64.890.031
16:04:03Q64.890.031
16:04:01Q64.890.031
16:03:35Q64.890.033,946

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-01-02 08:00U:LNTHNews ReleaseLantheus Announces Closing of SPECT Business Sale to SHINE Technologies
2025-11-24 08:30U:LNTHNews ReleaseLantheus to Present Florbetaben F 18 Data at CTAD 2025
2025-11-06 07:02U:LNTHNews ReleaseLantheus Reports Third Quarter 2025 Financial Results and Provides Business Update
2025-11-06 07:00U:LNTHNews ReleaseLantheus Announces Leadership Transition Plan
2025-10-30 08:30U:LNTHNews ReleaseLantheus Announces FDA Grants PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
2025-10-28 08:30U:LNTHNews ReleaseLantheus Announces FDA Acceptance of New Drug Application for MK-6240, a PET Imaging Agent Targeting Tau in Alzheimer's Disease
2025-10-23 08:30U:LNTHNews ReleaseLantheus to Host Third Quarter 2025 Earnings Conference Call and Webcast on November 6, 2025, at 8:00 a.m. Eastern Time
2025-09-24 01:00U:LNTHNews ReleaseLantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY(TM) (Piflufolastat F 18) in Japan
2025-09-02 08:30U:LNTHNews ReleaseLantheus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
2025-08-06 07:00U:LNTHNews ReleaseLantheus Reports Second Quarter 2025 Financial Results and Provides Business Update
2025-08-06 06:45U:LNTHNews ReleaseLantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent
2025-07-23 08:00U:LNTHNews ReleaseLantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time
2025-07-22 07:00U:LNTHNews ReleaseLantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D
2025-06-11 16:01U:LNTHNews ReleaseLantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting
2025-06-10 08:30U:LNTHNews ReleaseLantheus to Present at the 2025 Truist Securities MedTech Conference
2025-06-03 08:30U:LNTHNews ReleaseLantheus to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
2025-06-02 08:00U:LNTHNews ReleasePharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer
2025-05-07 07:00U:LNTHNews ReleaseLantheus Reports First Quarter 2025 Financial Results and Provides Business Update
2025-05-06 16:01U:LNTHNews ReleaseLantheus Announces Sale of SPECT Business to SHINE Technologies
2025-04-30 08:30U:LNTHNews ReleaseLantheus Announces Alzheimer's Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies